Recombinant pigeon pox virus vaccine

Details Recombinant pigeon pox virus vaccine Recombinant pigeon pox virus vaccine

C - Chemistry, Metallurgy

12

N

C12N 15/45 (2006.01) A61K 39/17 (2006.01) A61K 39/275 (2006.01) A61K 39/295 (2006.01) C07K 14/125 (2006.01) C12N 5/10 (2006.01) C12N 7/01 (2006.01) C12N 15/39 (2006.01) C12N 15/62 (2006.01) C12N 15/86 (2006.01) C12N 15/863 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2084064

2084064 9200372 PCTABS00010 The present invention provides a recombinant pigeon pox virus synthetically modified by the presence, in a non-essential region of the pigeon pox genome, of DNA not naturally occurring in pigeon pox virus. In a preferred embodiment of the invention, pigeon pox virus is modified by at least a portion of the Newcastle Disease virus F gene wherein the F gene is inserted within the thymidine kinase locus in the pigeon pox genome.

Affiliated with

Also associated with

Rating

Recombinant pigeon pox virus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant pigeon pox virus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant pigeon pox virus vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1623718